About
Repurposing drug
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
409
By Phase
PHASE1: 1PHASE3: 1
By Status
RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05879367Lead Sponsor
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PHASE1Recruiting
66 participants
Started: Jul 24, 2023 · Completed: Jun 30, 2026
NCT02796261Lead Sponsor
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
PHASE3Unknown
343 participants
Started: Jul 31, 2016 · Completed: Jun 30, 2023
Locations (1)
Headquarters
Palo Alto, CA, United States
Map
Loading map...